Pharmaceutical

EMA approves Bavarian Nordic’s mpox vaccine for teenagers

Data showed non-inferiority of immune response between adults and adolescents with Imvanex.

Sep 22, 2024 - 04:00
EMA approves Bavarian Nordic’s mpox vaccine for teenagers
Data showed non-inferiority of immune response between adults and adolescents with Imvanex.
Read the original article

Tags:

Previous Article

Sanofi eyes approval after MS therapy slows disease progression by 31%

Next Article

Magazine: Enhancing therapy adherence with prodrugs

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

TAS-117 by Taiho Pharmaceutical for Chondrosarcoma: Lik...

Jun 11, 2023

Opinion: The pink ribbon of breast cancer awareness needs a splash of blue for men

Opinion: The pink ribbon of breast cancer awareness nee...

Oct 28, 2023

Emergency medicine is grappling with a surprising problem: The prospect of too many physicians

Emergency medicine is grappling with a surprising probl...

Oct 28, 2023